Literature DB >> 1838150

Structure, biosynthesis and biological roles of monocyte-macrophage colony stimulating factor (CSF-1 or M-CSF).

V Praloran1.   

Abstract

CSF-1 or M-CSF is a homodimeric glycosylated protein purified to homogeneity through its hematopoietic growth factor properties. It has recently been cloned and sequenced as a unique gene encoding several m-RNAs and peptidic species. Its receptor has been identified as the c-fms protooncogene product expressed at the surface of all CSF-1 responsive cells as a transmembrane tyrosine kinase responsible for CSF-1 induced signal transduction. CSF-1 is permanently present in serum and several biological fluids at stable concentrations and can thus be considered as a hormone. In vivo concentrations are mainly regulated by binding, internalization and degradation of the CSF-1 molecule by hepatic and splenic macrophage receptors. Very little is known about the organs and cell types responsible for in vivo CSF-1 synthesis. In vitro, CSF-1 regulates the survival, proliferation and differentiation of the monocyte-macrophage lineage from progenitors to mature cells and activates several important functions of mature tissular macrophages. Recent results obtained with injections of recombinant CSF-1 show that interesting activities, e.g., as ADCC, NK or antiinfectious effects, that had been initially observed in vitro can also be induced in vivo. All these in vitro and in vivo data and the recent availability of large amounts of pure recombinant human CSF-1 point to the diagnostic value of CSF-1 concentration measurements in biological fluids and suggest a therapeutic role for CSF-1 infusion in cancer and infection therapy.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1838150

Source DB:  PubMed          Journal:  Nouv Rev Fr Hematol


  6 in total

1.  Doxorubicin resistance mediated by cytoplasmic macrophage colony-stimulating factor is associated with switch from apoptosis to autophagic cell death in MCF-7 breast cancer cells.

Authors:  Mengxia Zhang; Hailiang Zhang; Fan Tang; Yuhua Wang; Zhongcheng Mo; Xiaoyong Lei; Shengsong Tang
Journal:  Exp Biol Med (Maywood)       Date:  2016-07-24

2.  Circulating levels of the macrophage colony stimulating factor CSF-1 in primary and metastatic breast cancer patients. A pilot study.

Authors:  S M Scholl; R Lidereau; A de la Rochefordière; C C Le-Nir; V Mosseri; C Noguès; P Pouillart; F R Stanley
Journal:  Breast Cancer Res Treat       Date:  1996       Impact factor: 4.872

Review 3.  VEGF receptor signaling in vertebrate development.

Authors:  Joaquim Miguel Vieira; Christiana Ruhrberg; Quenten Schwarz
Journal:  Organogenesis       Date:  2010 Apr-Jun       Impact factor: 2.500

4.  Circulating levels of colony-stimulating factor 1 as a prognostic indicator in 82 patients with epithelial ovarian cancer.

Authors:  S M Scholl; C H Bascou; V Mosseri; R Olivares; H Magdelenat; T Dorval; T Palangié; P Validire; P Pouillart; E R Stanley
Journal:  Br J Cancer       Date:  1994-02       Impact factor: 7.640

5.  Plasma macrophage colony-stimulating factor levels during cardiopulmonary bypass with extracorporeal circulation.

Authors:  Y Denizot; P Fixe; E Cornu; N Nathan
Journal:  Mediators Inflamm       Date:  1996       Impact factor: 4.711

6.  Early risk prognosis of free-flap transplant failure by quantitation of the macrophage colony-stimulating factor in patient plasma using 2-dimensional liquid-chromatography multiple reaction monitoring-mass spectrometry.

Authors:  Jingzhi Yang; Juliane C Finke; Juncong Yang; Andrew J Percy; Uwe von Fritschen; Christoph H Borchers; Michael O Glocker
Journal:  Medicine (Baltimore)       Date:  2016-09       Impact factor: 1.889

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.